Royal Bank Of Canada Alpha Teknova, Inc. Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.29 - $2.81 $39 - $87	31 Added 33.7%	123 $0
Q1 2024 Nov 05, 2024	SELL	$2.41 - $3.88 $74 - $120	-31 Reduced 25.2%	92 $0
Q1 2024 May 15, 2024	SELL	$2.41 - $3.88 $72 - $116	-30 Reduced 24.59%	92 $0
Q4 2023 Feb 14, 2024	BUY	$1.85 - $3.73 $175 - $354	95 Added 351.85%	122 $0
Q3 2023 Nov 14, 2023	SELL	$1.66 - $3.83 $200 - $463	-121 Reduced 81.76%	27 $0
Q2 2023 Aug 14, 2023	SELL	$1.8 - $3.98 $367 - $811	-204 Reduced 57.95%	148 $0
Q1 2023 May 15, 2023	SELL	$2.74 - $6.25 $1,756 - $4,006	-641 Reduced 64.55%	352 $1,000
Q4 2022 Feb 14, 2023	BUY	$3.23 - $5.64 $2,961 - $5,171	917 Added 1206.58%	993 $5,000
Q3 2022 Nov 14, 2022	BUY	$3.34 - $9.2 $133 - $368	40 Added 111.11%	76 $0
Q2 2022 Aug 15, 2022	SELL	$6.39 - $16.24 $2,504 - $6,366	-392 Reduced 91.59%	36 $0
Q1 2022 May 16, 2022	SELL	$12.79 - $21.64 $15,220 - $25,751	-1,190 Reduced 73.55%	428 $6,000
Q4 2021 Feb 14, 2022	BUY	$17.49 - $26.72 $13,047 - $19,933	746 Added 85.55%	1,618 $33,000
Q3 2021 Nov 15, 2021	BUY	$17.47 - $27.49 $15,233 - $23,971	872 New	872 $22,000

5.4M

Ticker TKNO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 28,080,500
Market Cap $241M
Description
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.